RK Swamy starts FY27 with revenue growth and early operating leverage
Ask Iris
null
Frequently Asked Questions
Q1 FY27 consolidated total income was Rs 86 crores (Rs 8,581 lakhs), up 7% YoY. EBITDA was Rs 10.9 crores (Rs 1,092 lakhs), and PAT was Rs 3.5 crores (Rs 347 lakhs).
PBT increased 26% YoY to Rs 4.6 crores (from Rs 3.6 crores). EBITDA increased 24% YoY to Rs 10.9 crores. EBITDA margin improved to 13% from 11%.
The presentation groups operations into Integrated Marketing Communications, Data Analytics and MarTech (Hansa Customer Equity), and Full-service Market Research (Hansa Research).
It states that a significant portion of operating costs is relatively fixed and broadly similar across quarters. As revenue rises, incremental revenue can flow through to profits at a higher rate.
Yes. The company states that revenue tends to be higher in Q3 and Q4, and therefore revenues across quarters are not directly comparable.
The company lists five growth drivers: business as usual with current clients, healthcare segment solutions, brand and marketing consulting, a multi-country specialist panel of doctors, and continuing to build infrastructure to support marketing.
The proposed Digital Video Content Production Studio is described as an integrated production and post-production facility to meet growing demand for digital content and to reduce reliance on external production and outsourcing costs.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
